Parabilis Medicines, Inc. ( PBLS) - Stock Earnings
PBLS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -34.8 million USD | — USD |
| 2026Q1 | -45.3 million USD | — USD |
| 2026Q2 | -52.5 million USD | 148000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PBLS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -117.9 million USD | — USD |
| 2025 | -145.9 million USD | — USD |
| 2026 Est. | — | — |
PBLS
Price: $25.89
52 week price:
Earnings Per Share: -1.88 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.5 billion